<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-22</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-22</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>91</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>4</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç©ºé—´è½¬å½•ç»„ä¸å•ç»†èƒæŠ€æœ¯è”åˆæ­ç¤ºè‚ é“TRMç»†èƒå‘½è¿æ–°æœºåˆ¶ï¼›NKç»†èƒè”åˆæ²»ç–—æ™šæœŸèƒ°è…ºç™Œè·æ˜¾è‘—ç–—æ•ˆï¼Œå¹¶é¦–æ¬¡ç»˜åˆ¶å…ç–«ç³»ç»ŸåŠ¨æ€å˜åŒ–å›¾è°±ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- <strong>è‚¿ç˜¤å…ç–«æ²»ç–—</strong>ï¼šæ­ç¤ºè‚¿ç˜¤å…ç–«è€è¯æ–°é¶ç‚¹ï¼ˆBCL9ï¼‰ï¼Œæ¢ç´¢ä¹æ°§å·¨å™¬ç»†èƒåŠå¼‚å‹ç»†èƒç°‡ä¸­CD8+Tç»†èƒçš„æŠ—ç™Œæ½œåŠ›ã€‚<br />
- <strong>ç»†èƒè¡¨å‹ä¸åŠŸèƒ½ç ”ç©¶</strong>ï¼šé€šè¿‡å•ç»†èƒæŠ€æœ¯é‰´å®šç‰¹å®šç»†èƒè¡¨å‹ï¼ˆå¦‚ä¹æ°§å·¨å™¬ç»†èƒã€è¡°è€CD8Tç»†èƒï¼‰ä»¥å‘ç°é«˜åˆ†æ–‡ç« åˆ‡å…¥ç‚¹ã€‚<br />
- <strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šç»“åˆå•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€ä»£è°¢ç»„ç­‰æŠ€æœ¯ï¼Œå‘æ˜å…¬å¼€æ•°æ®é›†ä¸­çš„ç ”ç©¶äº®ç‚¹ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- <strong>ç©ºé—´è½¬å½•ç»„ä¸å•ç»†èƒè”åˆ</strong>ï¼šå®ç°å¯¹ç»†èƒå¾®ç¯å¢ƒå’Œåˆ†å­ç‰¹å¾çš„ç²¾ç»†è§£æã€‚<br />
- <strong>æ–°å‹é¶ç‚¹ä¸è¯ç‰©å¼€å‘</strong>ï¼šå‘ç°é¶å‘BCL9çš„æ–°å‹å…ˆå¯¼è¯ç‰©ï¼Œç”¨äºæ”»å…‹è‚ç™Œå…ç–«è€è¯ã€‚<br />
- <strong>å¤§è§„æ¨¡ç»†èƒå›¾è°±ç»˜åˆ¶</strong>ï¼šæ„å»º170ä¸‡Tç»†èƒå›¾è°±ï¼Œä¸ºç”Ÿä¿¡æ³¨é‡Šæä¾›â€œé»„é‡‘æ ‡å°ºâ€ã€‚</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
åˆ©ç”¨ç©ºé—´è½¬å½•ç»„å­¦è§£æå¿ƒè„ç‚ç—‡ç–¾ç—…çš„ç»†èƒåˆ†å­ç‰¹å¾ï¼Œä»¥åŠæ¢ç´¢è¡°è€å¾®ç¯å¢ƒåœ¨èƒ°è…ºç™Œè½¬ç§»ä¸­çš„å†³å®šæ€§ä½œç”¨ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ„ŸæŸ“ä¸å…ç–«ï¼šç ”ç©¶ç»“æ ¸åˆ†ææ†èŒã€é‡‘é»„è‰²è‘¡è„çƒèŒæ¯’ç´ å¯¹å…ç–«ç»†èƒçš„å½±å“ï¼Œè¯„ä¼°CARTç»†èƒåœ¨è‚¿ç˜¤æ²»ç–—ä¸­çš„æ•ˆèƒ½ã€‚<br />
- ç™Œç—‡ç ”ç©¶ï¼šè§£æå¤§éº»äºŒé…šå¯¹æ…¢æ€§é«“æ€§ç™½è¡€ç—…çš„è°ƒæ§ï¼Œæ¢ç´¢KRAS/ERK/JUNBä¿¡å·é€šè·¯åœ¨èƒ°è…ºç™Œä¸­çš„ä½œç”¨ï¼Œä»¥åŠé˜»æ–­ç™Œç»†èƒå‘æˆçº¤ç»´ç»†èƒè½¬ç§»çº¿ç²’ä½“ä»¥å…‹æœEGFRçªå˜è‚ºç™Œçš„TKIè€è¯æ€§ã€‚<br />
- è¡°è€ä¸å†ç”Ÿï¼šç ”ç©¶GLP-1Ræ¿€åŠ¨å‰‚åœ¨è¡°è€é‡å¡‘ä¸­çš„åº”ç”¨ï¼Œä»¥åŠæ¢ç´¢è¡°è€å¾®ç¯å¢ƒå¯¹èƒ°è…ºç™Œè½¬ç§»çš„å½±å“ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯é¦–æ¬¡ç”¨äºè§£æå¿ƒè„çº¤ç»´åŒ–ç»†èƒçš„åˆ†å­ç­¾åã€‚<br />
- å¤šç»„å­¦åˆ†æï¼ˆATAC-seq, RNA-seqï¼‰ç”¨äºç ”ç©¶ä¸­åç»’è¯èŸ¹çš„èœ•å£³æœŸè‚Œè‚‰ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç ”ç©¶å‘ç°é•¿éç¼–ç  RNA AFAP1-AS1 è°ƒæ§è‚ºè…ºç™Œä¸­ AXIN2 çš„æ›¿ä»£å‰ªæ¥ï¼Œè¯±å¯¼è€è¯æ€§ï¼Œä¸ºå…‹æœè‚ºç™Œè€è¯æä¾›äº†æ–°é¶ç‚¹ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢æ–°å† ç–«è‹—å¯¹ç™Œç—‡å…ç–«ç–—æ³•ç–—æ•ˆçš„å½±å“ã€‚<br />
- è¯„ä¼°å¡ç¡«æ¡‘å°¼è”åˆå°¼ä¼å•æŠ—æ²»ç–—æ™šæœŸèƒ°å¤–ç¥ç»å†…åˆ†æ³Œè‚¿ç˜¤çš„ç–—æ•ˆä¸å®‰å…¨æ€§ã€‚<br />
- æ­ç¤º ZNF526 åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­é€šè¿‡ä¸æ°¨é…¸ä»£è°¢å’ŒæŠ—æ°§åŒ–èƒ½åŠ›ä¿ƒè¿›è‚¿ç˜¤ç”Ÿé•¿çš„æœºåˆ¶ã€‚<br />
- é˜æ˜å‡‹äº¡ç»†èƒåˆ†æ³Œçš„ç²¾æ˜é…®åœ¨éª¨è‚‰ç˜¤ä¸­è¯±å¯¼åŒ–ç–—è€è¯çš„æœºåˆ¶ã€‚<br />
- ç ”ç©¶ DNMT3A R882H çªå˜åœ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ä¸­çš„ä½œç”¨åŠå…¶ä¸ç™½è¡€ç—…å¹²ç»†èƒçš„å…³ç³»ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç»“åˆæµå¼ç»†èƒæœ¯ã€è›‹ç™½è´¨ç»„è´¨è°±å’Œ RNA æµ‹åºç­‰æŠ€æœ¯ï¼Œæ·±å…¥è§£æéª¨è‚‰ç˜¤åŒ–ç–—è€è¯çš„ç»†èƒé€šè·¯ã€‚<br />
- åˆ©ç”¨ CRISPR æŠ€æœ¯ç›´æ¥çº æ­£æ‚£è€…ç™½è¡€ç—…ç»†èƒä¸­çš„ DNMT3A çªå˜ï¼Œæ¢ç´¢å…¶åœ¨ç–¾ç—…ç»´æŒä¸­çš„ä½œç”¨ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
åˆ©ç”¨å•ç»†èƒRNAæµ‹åºæ­ç¤ºäº†æ²¹èœï¼ˆBrassica rapaï¼‰å¶ç‰‡å‘è‚²ä¸­å…³é”®åŸºå› è°ƒæ§æœºåˆ¶ï¼›å‘ç°äº†é˜»æ–­FSP1è›‹ç™½å¯è¯±å¯¼è‚ºç™Œç»†èƒå‡‹äº¡ï¼Œä¸ºç™Œç—‡æ²»ç–—å¸¦æ¥æ–°é¶ç‚¹ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¤ç‰©å‘è‚²ç”Ÿç‰©å­¦ï¼šè§£ææ²¹èœå¶ç‰‡ç»´ç®¡æŸç»†èƒåˆ†åŒ–å’Œå½¢æ€å‘ç”Ÿã€‚<br />
- ç™Œç—‡æ²»ç–—ï¼šæ¢ç´¢FSP1è›‹ç™½åœ¨è‚ºç™Œç”Ÿå­˜ä¸­çš„ä½œç”¨åŠé¶å‘æ²»ç–—æ½œåŠ›ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å•ç»†èƒRNAæµ‹åºï¼šç²¾ç»†è§£æç»†èƒç±»å‹ç‰¹å¼‚æ€§åŸºå› è¡¨è¾¾ã€‚<br />
- è›‹ç™½åŠŸèƒ½é˜»æ–­ï¼šå¼€å‘æ–°å‹ç™Œç—‡æ²»ç–—ç­–ç•¥ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (29æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>Natureé‡ç£…ï½œç©ºé—´è½¬å½•ç»„+å•ç»†èƒæ­ç§˜è‚ é“TRMç»†èƒå‘½è¿ï¼šä»£ç å…¨å…¬å¼€ï¼Œå¯å¤ç°</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°åšå£«<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTç»†èƒã€å•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€è½¬å½•ç»„ã€è‚ é“<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11903307/ç ”ç©¶èƒŒæ™¯ç»„<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NDcxMzYwNg==&amp;mid=2247490959&amp;idx=1&amp;sn=69b560482c0230cf5064da2708fdf8ae" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>44.5åˆ†é¡¶åˆŠå‘æ–‡ï¼Œå•ç»†èƒé‰´å®šå‡ºä¹æ°§å·¨å™¬ç»†èƒè¿›è¡Œåç»­ç ”ç©¶ã€‚å‰æœ‰è¡°è€CD8Tï¼Œç°æœ‰ä¹æ°§å·¨å™¬ã€‚è¯†åˆ«æŸç§è¡¨å‹çš„XXç»†èƒå¯å‘é«˜åˆ†æ–‡ç« ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè¡°è€ã€Tç»†èƒã€å·¨å™¬ç»†èƒã€å•ç»†èƒ<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247493031&amp;idx=1&amp;sn=f7913ae765518c2c28dadb7ca59defcf" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>7+å•åŸºå› ç”Ÿä¿¡ï¼Œ2026å¹´å•åŸºå› å¦‚ä½•å‘æ–‡ï¼Ÿå¤§é‡ç©ºé—´è½¬å½•ç»„åˆ†æå¿…ä¸å¯å°‘ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç©ºé—´è½¬å½•ç»„ã€åŸºå› ç»„ã€è½¬å½•ç»„ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504009&amp;idx=1&amp;sn=396ad67131b5d6dfdf1c2ebc4188a51f" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>Nat Communä¸¨æ¨Šå˜‰/æ¨æ¬£è£/æœ±æ££/èƒ¡åšå›¢é˜Ÿï¼šä»æ–°é¶ç‚¹BCL9åˆ°å…ˆå¯¼è¯hsBCL9Z96ï¼Œâ€œåŠ çƒ­â€å†·è‚¿ç˜¤æ”»å…‹è‚ç™Œå…ç–«è€è¯</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šäººä½“è›‹ç™½è´¨ç»„å¯¼èˆªè®¡åˆ’<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€è€è¯<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507482&amp;idx=3&amp;sn=36925129753617b28a83044851909ddd" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>å•ç»†èƒ+ç©ºè½¬+ä»£è°¢ç»„ï¼Œå…¬å¼€æ•°æ®é›†æ‰¾å‡ºäº®ç‚¹å°±èƒ½å‘1åŒº12åˆ†</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡äºº<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢ã€ä»£è°¢ç»„ã€å•ç»†èƒ<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248655&amp;idx=7&amp;sn=e2de454ccc6f260fb140ef4ba4a42527" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>Cancer Cellé‡ç£…ï¼šè‚¿ç˜¤ç«Ÿè¢«è‡ªå·±äººèƒŒåˆºï¼çªå˜å¼•çˆ†å…ç–«æ²»ç–—</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡äºº<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€cancerã€å…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼š10æœˆ16æ—¥ï¼ŒCancer Cellå‘è¡¨äº†å¾·å·å¤§å­¦MDå®‰å¾·æ£®ç™Œç—‡ä¸­å¿ƒPadmanee Sharmaæ•™æˆå›¢é˜Ÿçš„é‡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248655&amp;idx=2&amp;sn=71d46d88734a8a6c36cd665f58f35e99" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>æ•ˆæœæ˜æ˜¾ï¼åŒ—äº¬åŒ»é™¢é©¬æ´/èµµäº‘åš/è‚–é£å›¢é˜ŸNKç»†èƒè”åˆæ²»ç–—æ™šæœŸèƒ°è…ºç™Œè‚¿ç˜¤æ˜¾ç€ç¼©å°ï¼Œé¦–æ¬¡ç»˜åˆ¶æ²»ç–—è¿‡ç¨‹ä¸­å…ç–«ç³»ç»ŸåŠ¨æ€å˜åŒ–å›¾è°±</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šè½¬åŒ–åŒ»å­¦ç½‘<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€NKç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šé¦–æ¬¡ç»˜åˆ¶äº†NKç»†èƒæ²»ç–—è¿‡ç¨‹ä¸­å…ç–«ç³»ç»Ÿçš„åŠ¨æ€å˜åŒ–å›¾è°±ï¼Œæ­ç¤ºäº†å“åº”æ²»ç–—çš„æ‚£è€…ä½“å†…ç‰¹å®šçš„NKç»†èƒå’ŒTç»†èƒäºšç¾¤çš„å˜åŒ–è§„å¾‹ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656510414&amp;idx=1&amp;sn=08f223a9fd6db4da0f760bc78e275f8a" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>è¯è¿›å…­ ï½œç°åœ¨æˆ‘ä»¬è¯¥å¦‚ä½•å­¦å•ç»†èƒåˆ†æå·¥å…·ï¼šSeuratï¼Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šå¡å°”ï¼Œä½ å¥½ã€‚è¿™æ˜¯è¿æ¥å“¥ç”Ÿä¿¡å®¶ä¹¦çš„ç¬¬ä¸ƒåå…­å°ã€‚å†…å«ä»£ç <br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533777&amp;idx=1&amp;sn=34dc466e068170ebd6d76d7b5b729c5a" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>èšç„¦ç¥ç»è°ƒæ§è‚¿ç˜¤ï¼Ÿä¸Šäº¤å¤§è¿™ç¯‡ 27 åˆ†ç»¼è¿°å¸®ä½ ä¸€æ¬¡è¯»æ‡‚å…³é”®æœºåˆ¶ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šåŒåŒ»æµäº‘Medfocus<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç¥ç»<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæ–‡ç« ç³»ç»Ÿæ¢³ç†äº†ç¥ç»ç³»ç»Ÿå¦‚ä½•é€šè¿‡ä¸åŒä¿¡å·åˆ†å­ç›´æ¥æˆ–é—´æ¥å½±å“è‚¿ç˜¤çš„ç”Ÿé•¿ã€æ‰©æ•£åŠå…¶å¾®ç¯å¢ƒï¼Œå¹¶æŒ‡å‡ºç¥ç»æ´»åŠ¨åŒæ ·ä¼šå·¦å³æ²»ç–—æ•ˆæœï¼Œä¸ºæœªæ¥å›´ç»•ç¥ç»â€”è‚¿ç˜¤è°ƒæ§è½´çš„æ–°å‹æ²»ç–—ç­–ç•¥æä¾›äº†æ–¹å‘ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzk3NTY2NDk1Nw==&amp;mid=2247488160&amp;idx=2&amp;sn=6d1e911c43ea82c02af34600176b579a" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>ã€Šè‡ªç„¶ã€‹ï¼šè¢«å¿½è§†çš„æŠ—ç™Œå…ç–«çœŸç›¸ï¼ç§‘å­¦å®¶è¯å®ï¼Œå¼‚å‹ç»†èƒç°‡ä¸­çš„CD8é˜³æ€§Tç»†èƒå¯åˆ†ç¦»ã€å¯æ‰©å¢ï¼Œä¸”å…·å¤‡è¶…å¼ºç™Œç»†èƒæ€ä¼¤æ´»æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå¥‡ç‚¹è‚¿ç˜¤æ¢ç§˜<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€Tç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæŠŠå’Œæ´—æ¾¡æ°´ä¸€èµ·å€’æ‰çš„å­©å­æ¡å›æ¥ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI4ODc5MDI5NA==&amp;mid=2247503534&amp;idx=1&amp;sn=25b02f029ebb9f6dc58264d93135ddbc" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 19 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-å…¬ä¼—å·">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (54æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE300819 å°é¼ çš®å†…æ„ŸæŸ“ç»“æ ¸åˆ†ææ†èŒåé¢ˆéƒ¨æ·‹å·´ç»“çš„å•ç»†èƒRNAæµ‹åºåˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šlymphã€regex:lymph(o|atic)?ã€RNA-seqã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Johannes Nemeth ; Katharina Kusejko ; CÃ©dric DollÃ© ; Edoardo Sarti ; Dat Mai ; Ana N Jahn ; Dong Liu ; Gregory S Olson ; Alan H DiercksSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIn mice, establishment of a contained and persistent yet non-pathogenic infection with Mtb ("contained Mtb infection", CMTB) rapidly and durably reduces tuberculosis disease burden after re-exposure through aerosol challenge. The bacteria are introduced by intradermal inoculation into the ear and are contained in the corresponsing cervical lymph node. Protection is associated with elevated activation of alveolar macrophages, the first cells that respond to inhaled Mtb, and accelerated recruitment of Mtb-specific T cells to the lung parenchyma. This study used single-cell RNA-seq to compare the cellularity and transcriptional profiles of innate immune cells in the cervical lymph node of naive mice and mice with CMTB.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300819" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE310786 è‘¡è„çƒèŒè‚ æ¯’ç´ Aå½±å“å•æ ¸ç»†èƒè½¬å½•å’Œå·¨å™¬ç»†èƒæåŒ–ï¼šå¯¹æ„ŸæŸ“å’Œç‚ç—‡ä¸­å…ç–«ååº”çš„æ„ä¹‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€macrophageã€monocyteã€inflammation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Claudia Arasa ; Khaleda Rahman Qasi ; David Brodin ; Manuel Mata Forsberg ; Eva Sverremark-EkstrÃ¶mSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensStaphylococcal enterotoxins (SE) crosslink the MHC-II on antigen-presenting cells (APC) with the T-cell receptor, inducing a polyclonal T-cell response. Although APCs are the initial targets of SE and are critical in shaping subsequent T-cell activation, the effects of SE on APC function remain poorly understood. This study investigates the immunomodulatory effects of staphylococcal enterotoxin A (SEA) on monocytes and their differentiation into monocyte-derived dendritic cells (moDC) or macrophages (MDM). Transcriptomic analyses of human monocytes via RNA sequencing revealed SEA-induced enrichment of gene pathways associated with inflammation, infection and dermatitis, effects that were amplified in the presence of T-cells. Phenotypic and functional characterization showed that SEA-primed monocytes differentiated into MDM with an altered polarization, deviating from classical M1/M2 pathways. SEA-primed MDM exhibited downregulayion of key markers including HLA-DR, CD80, CD86 and PD-L1. Functional assays demonstrated that SEA-primed MDM pushed hyperinflammatory T-cell responses, with significantly enhanced proliferation and IFN-Î³ secretion. In contrast, moDC retained robust antigen-presenting capabilities even upon SEA-priming. These findings provide mechanistic insights into SEA-mediated immune modulation, illustrating how SEA reprograms MDM functions and amplify proinflammatory T-cell responses. This advances our understanding of superantigen-driven immune interactions, offering a foundation for developing therapeutic strategies to mitigate superantigen-mediated immune conditions.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310786" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE248347 åˆ©ç”¨ç©ºé—´è½¬å½•ç»„å­¦è§£æå®éªŒæ€§è‡ªèº«å…ç–«æ€§å¿ƒè‚Œç‚ä¸­å¿ƒè„æˆçº¤ç»´ç»†èƒçš„åˆ†å­ç‰¹å¾</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcardiacã€spatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Monika Stefanska ; Katarzyna Sarad ; Marta Kot ; Martyna Strzelec ; Daria KrzysztofikSeries Type : OtherOrganism : Mus musculusMyocarditis is a severe inflammatory cardiac disease that can progress to dilated cardiomyopathy and heart failure. Experimental autoimmune myocarditis (EAM) represents an animal model of acute myocarditis, which is followed by the development of post-inflammatory cardiac fibrosis and systolic dysfunction. In this model, cardiac inflammation is characterized by the massive influx of myeloid infiltrates and is paralleled by the activation of extracellular matrix-producing cardiac fibroblasts. 6â€“8-week-old BALB/c mice were immunized with Î±MyHC peptide together with Complete Freundsâ€™ Adjuvant to induce EAM. Heart tissues were isolated, embedded in OTC, sectioned into 10 Âµm-thick fragments, and placed on a 10x Genomics Visium Gene Expression Slide. Single-cell spatial libraries were prepared using 10x Genomics Visium protocols, and the sequencing was performed using Illumina Chemistry. Single-cell RNA sequencing data was analyzed using RStudio software. In our analysis, we included three biological time points: a healthy heart (d0), acute myocarditis (d19). Following sequencing, we analyzed 3789 spots under the tissue. We identified the main cell populations present in the mouse heart, including fibroblasts, immune cells, endothelial cells, smooth muscle cells, and cardiomyocytes. Subset analysis on cardiac fibroblasts resulted in the presence of four different subsets (FB1â€“FB6). Subset FB3 has a myofibroblastic signature defined by the expression of, among others, Acta2, Postn, Vim, Col1a1 and Col3a1. This subset is transiently present at d19 of EAM. Spatial analysis of infiltrating immune cells characterized by the expression of, e.g., Ly6c1 and Lyz2 resulted in the presence of five subsets (INF1â€“INF5). The INF4 subset is present only at acute myocarditis phase (d19) and is spatiotemporally colocalized with the myofibroblastic subset(FB3). Our data indicate that myofibroblasts and infiltrating immune cells colocalize within the tissue during acute phase of myocarditis. This may indicate active molecular interplay between inflammatory cells and cardiac fibroblasts.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248347" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE305108 å¤§éº»äºŒé…šå¯¹æ…¢æ€§ç²’ç»†èƒç™½è¡€ç—…ç»†èƒç³»å½±å“çš„ç”Ÿç‰©ä¿¡æ¯å­¦å·®å¼‚è¡¨è¾¾åˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€bioinformaticsã€differential expression<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Petar P DonchevSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensChronic myeloid leukemia (CML) is the first clonal myeloproliferative disorder of the pluripotent stem cell to be associated with a specific genetic abnormality, the Philadelphia chromosome, bearing the BCR-ABL1 fusion oncogene. First treatment option for control of the chronic phase of CML are the tyrosine kinase inhibitors (TKIs), though alternative treatments are necessary for resistant cases. Cannabidiol (CBD), one of the major constituents of hemp oil exerts a broad range of pharmacological effects in various malignancies, yet its molecular mechanisms in leukemia remain unclear. In the present study, Imatinib-sensitive K-562S cells were subjected to CBD treatment (IC50: 17.69 Î¼M) for 4 and 12 hours, followed by RNA sequencing to identify differentially expressed genes (DEGs). The consecutive transcriptomic profiling revealed 3518 DEGs at 12 hours and 3433 DEGs at 4 hours of treatment, showing significant modulation of metallothionein-regulated oxidative stress responses (MT1, MT2, SLC30A2), p53-mediated apoptosis (TP53TG3, DDIT4, BBC3, CHAC1, NOXA1, DAPK2), alteration in immune signaling pathways, including type I interferon activation, PI3K-Akt-mTOR and Toll-like receptor signaling, crucial in leukemia progression, as well as shifts in lipid metabolism and mitochondrial homeostasis. The results presented in this study invigorate the considerable potential of CBD to induce broad transcriptional and signaling alterations, related to immune modulation, apoptosis, and metabolic processes in K-562S cells. These findings provide new insights in the therapeutic potential of CBD and lay the groundwork for further investigation into its precision applications in hematological malignancies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305108" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE298701 è¡°è€å¾®ç¯å¢ƒæ˜¯èƒ°è…ºç™Œå…ç–«æ’æ–¥å’Œè½¬ç§»å‘½è¿çš„å†³å®šå› ç´ </strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€aging<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Priyanka Gupta ; Cosimo CommissoSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAging is a critical yet understudied determinant in pancreatic ductal adenocarcinoma (PDAC). Despite a strong epidemiological association with age, conventional PDAC preclinical models fail to capture the histopathological and stromal complexities that emerge in older organisms. Using an age-relevant syngeneic orthotopic model, we demonstrate that organismal aging accelerates PDAC progression and metastasis. Through transcriptomic profiling, we identify a conserved extracellular matrix gene signature enriched in cancer-associated fibroblasts (CAFs) from aged tumors, consistent with an augmented fibrotic landscape that supports immunosuppression, metastatic tropism, and poor prognosis. To directly test the functional impact of stromal aging, we employed heterochronic co-implantation models, revealing that revitalizing the aged tumor stroma with young CAFs restores immune infiltration and attenuates metastasis in older hosts. Conversely, aged CAFs, while immunosuppressive, fail to enhance metastasis in young hosts, suggesting that a youthful microenvironment exerts dominant regulatory control over disease progression. These findings demonstrate that stromal age is a critical modulator of both immune exclusion and metastatic behavior in PDAC. Importantly, our work establishes a new conceptual framework for understanding how aging shapes the tumor microenvironment in PDAC and opens a fertile avenue of investigation into age-specific stromal regulation. Moreover, this work raises compelling questions about the underlying molecular mechanismsâ€”questions now accessible through our modelsâ€”and lays the foundation for future efforts to therapeutically target stromal aging in PDAC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298701" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE307506 è‡´ç™Œ KRAS/ERK/JUNB ä¿¡å·é€šè·¯æŠ‘åˆ¶èƒ°è…ºç™Œä¸­çš„åˆ†åŒ–è°ƒèŠ‚å› å­ GATA6</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€regex:onco(logy|logist|gene|genic)ã€KRAS<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zheng Zhong ; David VirshupSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensGATA6 is a master regulator of differentiation in the pancreas and its expression levels determine the two main molecular subtypes of pancreatic cancer. High GATA6 contributes to the â€œclassicalâ€ pancreatic cancer subtype, which is associated with a higher degree of tumor differentiation and better disease prognosis. However, why GATA6 expression varies across pancreatic cancers and what regulate GATA6 expression remain elusive. Here we report that the oncogenic KRAS-activated ERK signaling suppresses GATA6 transcription in pancreatic cancers. GATA6 mRNA levels inversely correlated with KRAS/ERK activity in pancreatic tumors. A genome-wide CRISPR screen in a GATA6-EGFP reporter knockin cell line identified JUNB as the ERK-regulated transcriptional repressor for GATA6. Active ERK stabilizes JUNB protein while KRAS/ERK inhibition led to ubiquitin-independent proteasomal degradation of JUNB and increased transcription of GATA6. Up-regulation of GATA6 enhanced chemosensitivity of pancreatic cancer cells and KRAS/ERK inhibitors synergized with chemotherapy in a GATA6-dependent manner. Our study identifies how oncogenic KRAS/ERK signaling suppresses GATA6 to cause dedifferentiation in pancreatic cancer. Combining KRAS/ERK inhibitors with standard-of-care chemotherapies could be a promising therapeutic strategy for treating pancreatic cancers.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307506" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE308504 SAMåˆæˆé…¶å¯¹ä»£è°¢å’Œçº¿ç²’ä½“çš„ç‰¹å¼‚æ€§å½±å“æ˜¯ç§€ä¸½éšæ†çº¿è™«è€çƒ­åº”æ¿€çš„åŸºç¡€</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolismã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Athena L Munden ; Dominique S Lui ; Daniel P Higgins ; Matthew P Fanelli ; Thien-Kim Ngyuen ; Maria Ericsson ; Adwait A Godbole ; Jessica B Spinelli ; John Haley ; Caroline Lewis ; Daniel Promislow ; Benjamin Harrison ; Daniel Raftery ; Danijel Djukovic ; Dana L Miller ; Amy K WalkerSeries Type : Expression profiling by high throughput sequencingOrganism : Caenorhabditis elegansS-adenosylmethionine (SAM), produced by SAM synthases, is critical for various cellular regulatory pathways and the synthesis of diverse metabolites. Studies have often equated the effects of knocking down one synthase with broader SAM-dependent outcomes such as histone methylation or phosphatidylcholine (PC) production. However, many organisms express multiple synthase genes including humans and Caenorhabditis elegans. Evidence in C. elegans, which possesses an expanded family of SAM synthases, suggest that the enzymatic source of SAM impacts its function. For instance, loss of sams-1 leads to enhanced heat shock survival and increased lifespan, whereas reducing sams-4 adversely affects heat stress survival. Here, we reveal that loss of sams-1 exerts age-dependent effects on nuclear-encoded mitochondrial gene expression, mitochondrial metabolites, and mitophagy. Notably, we find that that SAMS-1 exerts synthase-specific effects on PC production. We propose a mechanistic framework wherein the reduced SAM from SAMS-1 acts through PC to impact mitochondrial fission and mitophagy, thereby enhancing survival during heat stress. This study highlights multifaceted roles of SAM across metabolic pathways and synthase-specific SAM functions.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308504" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE272489 BXDé‡ç»„è¿‘äº¤ç³»å°é¼ è‚ é“å¾®ç”Ÿç‰©ç¾¤ä¸èƒ†æ±é…¸ç›¸äº’ä½œç”¨çš„é—ä¼ å’Œé¥®é£Ÿå†³å®šå› ç´ </strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Johan Auwerx ; Kristina Schoonjans ; Xiaoxu Li ; Alessia Perino ; Hao LiSeries Type : Expression profiling by arrayOrganism : Mus musculusTranscriptome data measured by microarray in proximal colon of the BXD mouse genetic diversity model under a standard chow or a high fat diet at a postprandial state.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272489" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE310783 å¯¹çŒèƒƒç»™äºˆæ°´æˆ–Î²-ç¾ŸåŸºä¸é…¸é…¯çš„å°é¼ ä½“å†…å¾ªç¯41BBzeta CART19ç»†èƒè¿›è¡Œå•ç»†èƒRNAæµ‹åº</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Shan Liu ; Puneeth Guruprasad ; Maayan Levy ; Marco RuellaSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensSingle-cell gene expression of circulating 41BBzeta CART19 cells isolated from lymphoma-bearing NSG mice treated with daily oral gavage of water or beta-hydroxybutyrate. Cells were captured and processed using 10X 3' GEX Reagent Kit v2<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310783" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE280382 GLP-1Ræ¿€åŠ¨å‰‚çš„åŠŸèƒ½æ€§å’Œå¤šç»„å­¦æŠ—è¡°è€ç ”ç©¶[æ‰¹é‡RNAæµ‹åº]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šagingã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Andrew J. Kwok ; Junzhe Huang ; Ho KoSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIdentifying readily implementable methods that can effectively counteract aging is urgently needed for tackling age-related degenerative disorders. Here, we conducted functional assessments and deep molecular phenotyping in the aging mouse to demonstrate that glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment attenuates body-wide age-related changes. In male mice treated with a GLP-1RA from 11 months of age for 30 weeks, we observed improvements in physical and cognitive performance, alongside age-counteracting effects that are prominently evident at multiple omic levels. These span the transcriptomes and DNA methylomes of various tissues, organs and circulating white blood cells, as well as the plasma metabolome. Importantly, the beneficial effects are specific to the aging mice, not young adults, and are achieved with a relatively low dosage of GLP-1RA which has a negligible impact on food consumption and body weight. In older mice treated with a GLP-1RA from 18 months of age for 13 weeks, the molecular rejuvenation effects are even more prominent and generally dependent on hypothalamic GLP-1R, pointing to a brain-body axis of aging modulation. We benchmarked the GLP-1RA age-counteracting effects against those of mTOR inhibition, a well-established anti-aging intervention, observing a strong resemblance across the two strategies. Our findings have broad implications for understanding the mechanistic basis of the clinically observed pleiotropic effects of GLP-1RAs, the design of intervention trials for age-related diseases, and the development of anti-aging-based therapeutics.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280382" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 44 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (6æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨6æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>æ–°å† ç–«è‹—èƒ½å¦æå‡ç™Œç—‡å…ç–«ç–—æ³•çš„ç–—æ•ˆï¼Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡ã€å…ç–«ã€ç–«è‹—<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1991612496069373952/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>å¡ç¡«æ¡‘å°¼è”åˆå°¼ä¼å•æŠ—ç”¨äºæ™šæœŸèƒ°å¤–ç¥ç»å†…åˆ†æ³Œè‚¿ç˜¤ï¼ˆepNETï¼‰çš„äºŒæœŸä¸´åºŠè¯•éªŒ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç¥ç»<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: èƒŒæ™¯ï¼šå¡æ³¢æ›¿å°¼æ˜¯ä¸€ç§å¤šæ¿€é…¶æŠ‘åˆ¶å‰‚ï¼Œèƒ½æ”¹å–„æ™šæœŸèƒ°å¤–ç¥ç»å†…è„å†…ç‰¹ï¼ˆepNETï¼‰æ‚£è€…çš„æ— è¿›å±•ç”Ÿå­˜æœŸï¼ˆPFSï¼‰ã€‚å¡æ›¿æ›¿å°¼é€šè¿‡å‡å°‘è°ƒæ§ T ç»†èƒå’Œ CD14+å•æ ¸ç»†èƒçš„å­˜åœ¨ï¼Œä½¿è‚¿ç˜¤å¾®ç¯å¢ƒå¯¹å…ç–«ç»†èƒæ›´ä¸ºå‹å¥½ã€‚æœ¬è¯•éªŒæ¢è®¨äº†å¡æ›¿å°¼ä¸å°¼æ²ƒåˆ©å•æŠ—è”åˆä½¿ç”¨åœ¨ epNET æ™šæœŸæ‚£è€…çš„ç–—æ•ˆå’Œå®‰å…¨æ€§ã€‚æ–¹æ³•ï¼šå¼€æ”¾æ ‡ç­¾å•è‡‚ II æœŸè¯•éªŒï¼Œæ‹›å‹Ÿäº†æ™šæœŸ epNET æ‚£è€…ã€‚æ‚£è€…åœ¨ç¬¬ 1 å¤©å’Œç¬¬ 15 å¤©é™è„‰æ³¨å°„ 240 æ¯«å…‹å°¼æ²ƒåˆ©å•æŠ—ï¼Œ28 å¤©å‘¨æœŸå†…æ¯æ—¥å£æœ 40 æ¯«å…‹å¡è‹¯æ›¿å°¼ã€‚ä¸»è¦ç»ˆç‚¹ä¸º RECIST v1.1 çš„å®¢è§‚ååº”ç‡ï¼ˆORRï¼‰ã€‚é‡‡ç”¨è¥¿è’™æ–¯ä¸¤é˜¶æ®µè®¾è®¡ï¼Œç¬¬ä¸€é˜¶æ®µæ‹›å‹Ÿäº† 19 åæ‚£è€…ã€‚æ¬¡è¦ç›®æ ‡åŒ…æ‹¬å…ç–«ç›¸å…³ååº”æ ‡å‡†ï¼ˆirRECISTï¼‰ã€PFS å’Œå®‰å…¨æ€§ã€‚æ¢ç´¢æ€§ç›®æ ‡åŒ…æ‹¬å…ç–«ä¸è¡€ç®¡ç”Ÿæˆè›‹ç™½è´¨ç»„è°±ä¹‹é—´çš„ç›¸å…³æ€§åŠä¸´åºŠç»“å±€ã€‚ç»“æœï¼š19 åçº³å…¥æ‚£è€…ä¸­æœ‰ 18 ä¾‹å¯¹ç¼“è§£æœ‰æ•ˆã€‚æœ€ä½³ååº”ä¸ºéƒ¨åˆ†ååº” 1ï¼ˆ5%ï¼‰ã€ç¨³å®šç–¾ç—… 16ï¼ˆ90%ï¼‰å’Œè¿›å±•æ€§ç–¾ç—…<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1991630681216757760/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>ZNF526 é€šè¿‡å¢å¼º TNBC ä¸­ SHMT1 ä¾èµ–æ€§çš„ä¸æ°¨é…¸ä»£è°¢å’ŒæŠ—æ°§åŒ–èƒ½åŠ›ï¼Œä¿ƒè¿›è‚¿ç˜¤ç”Ÿé•¿</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ä¸‰é˜´æ€§ä¹³è…ºç™Œï¼ˆTNBCï¼‰æ˜¯ä¸€ç§ä¾µè¢­æ€§æ¶æ€§è‚¿ç˜¤ï¼Œæ²»ç–—é€‰æ‹©æœ‰é™ä¸”é¢„åè¾ƒå·®ã€‚å°½ç®¡ ZNF526 ä¸­çš„å•æ ¸è‹·é…¸å¤šæ€æ€§ rs3810151ï¼ˆp.Val94Alaï¼‰å·²è¢«ç¡®å®šä¸ºä¹³è…ºç™Œæ˜“æ„Ÿä½ç‚¹ï¼Œä½† ZNF526 åœ¨ TNBC ä¸­çš„åŠŸèƒ½ä½œç”¨å’Œæœºåˆ¶åŸºç¡€ä»ä¸æ¸…æ¥šã€‚æœ¬ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬è§‚å¯Ÿåˆ° ZNF526 åœ¨ TNBC ä¸­è¡¨è¾¾è¾ƒé«˜ï¼Œå…¶å‡é«˜çš„è¡¨è¾¾ä¸è¾ƒå·®çš„ä¸´åºŠç»“å±€ç›¸å…³ã€‚åŠŸèƒ½æ€§æ£€æµ‹æ˜¾ç¤ºï¼ŒZNF526 çš„è¿‡è¡¨è¾¾ä¿ƒè¿› TNBC ç»†èƒç”Ÿé•¿ï¼Œè€Œå…¶æ•²ä½ä½œç”¨åˆ™æŠ‘åˆ¶è‚¿ç˜¤ç”Ÿé•¿ã€‚æœºåˆ¶ä¸Šï¼Œæˆ‘ä»¬å‘ç° ZNF526 æ¿€æ´» SHMT1 è¡¨è¾¾ï¼Œè¿›è€Œå¢å¼ºä¸æ°¨é…¸-ç”˜æ°¨é…¸-ä¸€ç¢³ï¼ˆSGOCï¼‰ä»£è°¢é€šè·¯çš„é€šé‡ã€‚è¿™ç§ä»£è°¢æ¿€æ´»å¢åŠ äº†è°·èƒ±ç”˜è‚½ï¼ˆGSHï¼‰çš„äº§ç”Ÿï¼Œé™ä½æ´»æ€§æ°§ï¼ˆROSï¼‰æ°´å¹³ï¼Œå¹¶å¢å¼ºç»†èƒæŠ—æ°§åŒ–é˜²å¾¡ï¼Œä»è€Œä¿ƒè¿› TNBC çš„è¿›å±•ã€‚æˆ‘ä»¬çš„å‘ç°è¡¨æ˜ï¼ŒZNF526 æ˜¯é€šè¿‡ SHMT1 ä»‹å¯¼çš„ä»£è°¢è°ƒæ§ï¼Œèƒ½å¤Ÿè°ƒèŠ‚ TNBC æ°§åŒ–è¿˜åŸå¹³è¡¡ï¼Œä½¿å…¶æˆä¸º TNBC æ½œåœ¨çš„æ²»ç–—é¶ç‚¹ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1991629530022916096/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>å‡‹äº¡ç»†èƒåˆ†æ³Œçš„ç²¾æ˜é€šè¿‡è°ƒèŠ‚éª¨è‚‰ç˜¤ä¸­çš„Î²é“¾ç¯è›‹ç™½æ´»æ€§ï¼Œå¢å¼ºåŒ–ç–—è€è¯æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ï¼šåŒ–ç–—è€è¯æ€§ä»æ˜¯éª¨è‚‰ç˜¤ï¼ˆOSï¼‰æ²»ç–—ä¸­çš„å…³é”®éšœç¢ã€‚æœ¬ç ”ç©¶æ—¨åœ¨é˜æ˜ç²¾æ˜é…®ï¼ˆSPDï¼‰åœ¨éª¨è‚‰ç˜¤åŒ–å­¦è€è¯ä¸­çš„ä½œç”¨åŠå…¶æ½œåœ¨æœºåˆ¶ã€‚å®éªŒè®¾è®¡ï¼šåˆ©ç”¨ OS ç»†èƒç³»å’Œå¼‚ç§ç§»æ¤ï¼Œæˆ‘ä»¬ç»“åˆæµå¼ç»†èƒæœ¯ã€è¥¿æ–¹å°è¿¹æ³•ã€è›‹ç™½è´¨ç»„è´¨è°±å’Œ RNA æµ‹åºï¼Œä»¥è¡¨å¾ SPD é©±åŠ¨çš„ç»†èƒé€šè·¯å’Œè€è¯ç‰¹å¾å˜åŒ–ã€‚æˆ‘ä»¬æµ‹è¯•äº†å•ç”¨æˆ–è”åˆæ ‡å‡†åŒ–ç–—è¯ç‰©æŠ‘åˆ¶ SPD ç”Ÿç‰©åˆæˆæ˜¯å¦èƒ½æ”¹å–„ä½“å†…æ²»ç–—ååº”ã€‚ç»“æœï¼šç»è¿‡åŒ–ç–—ï¼Œæ— è®ºæ˜¯é¡ºé“‚ï¼ˆCDPï¼‰è¿˜æ˜¯å¤šæŸ”æ¯”æ˜Ÿï¼ˆDOXï¼‰ï¼Œå‡‹äº¡çš„ OS ç»†èƒè¡¨ç°å‡ºé¸Ÿæ°¨é…¸è„±ç¾§é…¶ 1ï¼ˆODC1ï¼‰å’Œç²¾è„šåˆé…¶ï¼ˆSRMï¼‰ä¸Šè°ƒï¼Œè¿™ä¸¤ç§é…¶æ˜¯ SPD åˆæˆçš„å…³é”®é…¶ï¼Œå¯¼è‡´è¯¥å¤šèƒºæ°´å¹³å‡é«˜ã€‚SPD é™ä½äº† CDP å’Œ DOX åœ¨ OS ç»†èƒä¸­çš„æ²»ç–—æ•ˆæœï¼Œæ— è®ºæ˜¯ä½“å¤–è¿˜æ˜¯ä½“å†…ã€‚ä»æœºåˆ¶ä¸Šçœ‹ï¼ŒSPD å¢å¼ºÎ²-é“¾è›‹ç™½æ´»æ€§ï¼Œè¿›è€Œä¸Šè°ƒä¸ç™Œç—‡å¹²ç»†èƒå’Œ ATP ç»“åˆç›’ï¼ˆABCï¼‰è½¬è¿è›‹ç™½ç›¸å…³çš„åŸºå› ï¼Œè¿™ä¸¤è€…éƒ½ä¸è¯ç‰©è€è¯æ€§æœ‰å…³ã€‚æ­¤å¤–ï¼Œä½¿ç”¨ DFMO è¯ç†æŠ‘åˆ¶ SPD åˆæˆæ˜¾è‘—æé«˜äº†<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1991630685385895936/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>DNMT3A R882H åœ¨åŸå‘æ€§äººç±»æ€¥æ€§é«“ç™½è¡€ç—…ä¸­å¹¶éç–¾ç—…ç»´æŒå¿…éœ€ï¼Œä½†ä¸ç™½è¡€ç—…å¹²ç»†èƒé¢‘ç‡å¢åŠ ç›¸å…³</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: äººç±»ç™Œç—‡ä¸­çš„é—ä¼ çªå˜æ­£åœ¨è¢«å…¨é¢ç»˜åˆ¶ï¼Œä½†ç™Œç—‡ç”Ÿç‰©å­¦ä¸­çš„ä¸€ä¸ªæ ¹æœ¬é—®é¢˜æ˜¯ï¼Œè¿™äº›çªå˜æ˜¯å¦åœ¨ç™Œç—‡å¯åŠ¨ã€æ—¢æœ‰ç™Œç—‡ç»´æŒæˆ–ä¸¤è€…å…¼å…·çš„åŠŸèƒ½æ€§éœ€æ±‚ä¸­å­˜åœ¨ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬å°†åœ¨äººç±»æ€¥æ€§éª¨é«“æ€§ç™½è¡€ç—…ï¼ˆAMLï¼‰çš„èƒŒæ™¯ä¸‹ç ”ç©¶è¿™ä¸ªé—®é¢˜ï¼Œå…¶ä¸­ DNMT3AR882 é”™ä¹‰çªå˜å¸¸åœ¨ç™½è¡€ç—…å‰çš„å…‹éš†é€ è¡€ä¸­æ—©æœŸå‡ºç°ï¼Œå¹¶ç ´å DNA ç”²åŸºåŒ–æ™¯è§‚ä»¥å¯åŠ¨ç™½è¡€ç—…ã€‚æˆ‘ä»¬å¼€å‘äº†åŸºäº CRISPR çš„æ–¹æ³•ï¼Œç›´æ¥çº æ­£æ‚£è€…ç™½è¡€ç—…ç»†èƒä¸­çš„ DNMT3AR882 çªå˜ã€‚ä»¤äººæƒŠè®¶çš„æ˜¯ï¼ŒDNMT3AR882 çªå˜åœ¨ç–¾ç—…ç»´æŒä¸­å¤§å¤šå¯æ›¿ä»£ã€‚ç”¨é‡ç”Ÿå‹ DNMT3A æ›¿ä»£ DNMT3AR882 çªå˜ä½“å¹¶æœªå‰Šå¼± AML ç»†èƒä½“å†…ç§»æ¤èƒ½åŠ›ï¼Œä¸” DNA ç”²åŸºåŒ–ä»…æœ‰å¾®å°æ”¹å˜ã€‚ç»¼åˆæ¥çœ‹ï¼ŒDNMT3AR882 çªå˜æœ€åˆæ˜¯ AML å¯åŠ¨çš„å¿…è¦æ¡ä»¶ï¼Œä½†åœ¨ç–¾ç—…ç»´æŠ¤ä¸­åŸºæœ¬å¯æ›¿ä»£ã€‚å¯åŠ¨ç™ŒåŸºå› ä¸ç»´æŒç™Œç—‡åŸºå› çš„ä¸åŒè¿™ä¸€è§‚ç‚¹å¯¹ç™Œç—‡è¿›åŒ–å’Œæ²»ç–—å…·æœ‰é‡è¦æ„ä¹‰ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1991630688758116352/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>é•¿éç¼–ç  RNA AFAP1-AS1 é€šè¿‡ä¿ƒè¿› SRSF ç›¸åˆ†ç¦»ï¼Œä¿ƒè¿› AXIN2 çš„æ›¿ä»£å‰ªæ¥ï¼Œä»è€Œè¯±å¯¼è‚ºè…ºç™Œä¸­çš„è€è¯æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è‚ºç™Œç›®å‰åœ¨å…¨çƒæ¶æ€§è‚¿ç˜¤ä¸­å‘ç—…ç‡å’Œæ­»äº¡ç‡æœ€é«˜ï¼Œå…¶ä¸­è‚ºè…ºç™Œæ˜¯æœ€å¸¸è§ä¸”è‡´å‘½çš„äºšå‹ã€‚åŒ–ç–—å’Œé¶å‘æ²»ç–—ä»æ˜¯è‚ºè…ºç™Œçš„æ ‡å‡†æ²»ç–—ï¼Œä½†è‚¿ç˜¤è€è¯æ€§ä»æ˜¯ä¸´åºŠä¸Šçš„é‡è¦æŒ‘æˆ˜ã€‚æœ¬ç ”ç©¶å‘ç°ï¼Œè‚ºè…ºç™Œä¸­è¡¨è¾¾è¾ƒé«˜çš„é•¿éç¼–ç  RNA è‚ŒåŠ¨è›‹ç™½ä¸çŠ¶è›‹ç™½ 1 åä¹‰ RNA 1ï¼ˆAFAP1-AS1ï¼‰é€šè¿‡æ‹›å‹Ÿä¸æ°¨é…¸å’Œç²¾æ°¨é…¸å¯Œé›†æ‹¼æ¥å› å­ 1 å’Œ 3ï¼ˆSRSF1 å’Œ SRSF3ï¼‰è°ƒæ§ RNA æ›¿ä»£å‰ªæ¥ï¼Œä¿ƒè¿›å…¶æ¶²ç›¸åˆ†ç¦»ã€‚åœ¨å—å½±å“çš„å‰ªæ¥äº‹ä»¶ä¸­ï¼Œå…³é”®è°ƒæ§åŸºå›  AXIN2 çš„ 7 å¤–æ˜¾å­è·³è·ƒï¼Œè¯¥åŸºå› å‚ä¸ Wnt/Î²-catenin ä¿¡å·é€šè·¯ï¼Œæœ€æ˜¾è‘—åœ°å— AFAP1-AS1 è°ƒæ§ï¼Œå¯¼è‡´æˆªæ–­ AXIN2 å¼‚æ„ä½“ï¼ˆAXIN2-Sï¼‰çš„ç¿»è¯‘ã€‚è¯¥å¼‚æ„ä½“ä¿ƒè¿›ç»†èƒæ ¸å†…Î²-catenin çš„ç§¯ç´¯ï¼Œå¹¶æŒç»­æ¿€æ´» Wnt/Î²-catenin ä¿¡å·é€šè·¯ï¼Œæœ€ç»ˆä¿ƒè¿›è‚ºè…ºç™Œçš„è¯ç‰©è€è¯æ€§ã€‚æˆ‘ä»¬çš„ç ”ç©¶æ­ç¤ºäº† AFAP1-AS1 é€šè¿‡è°ƒèŠ‚å‰ªæ¥å› å­ç›¸åˆ†ç¦»è°ƒèŠ‚ RNA æ›¿ä»£å‰ªæ¥çš„æ–°åŠŸèƒ½ã€‚è¯¥æœºåˆ¶å‡¸æ˜¾äº†<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1991629529179860992/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>åˆ©ç”¨å•ç»†èƒæŠ€æœ¯æ·±å…¥äº†è§£ç”˜è“å‹æ²¹èœå¶ç‰‡çš„å‘è‚²è¿‡ç¨‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSingle cell RNA sequencing reveals how Brassica rapa leaf vascular cells develop and differentiate, uncovering key regulatory genes shaping xylem, phloem, and overall leaf morphogenesis...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/single-cell-insights-into-leaf-development-in-brassica-rapa/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>é˜»æ–­å•ä¸ªè›‹ç™½è´¨å³å¯è¿«ä½¿ç™Œç»†èƒè‡ªæˆ‘æ¯ç­</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, with many cancer cells essentially triggering their own self-destruct mode. The work points to a fresh strategy for targeting stubborn lung cancers.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251120002606.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>è‚¿ç˜¤</td>
<td>9</td>
</tr>
<tr>
<td>cancer</td>
<td>9</td>
</tr>
<tr>
<td>å•ç»†èƒ</td>
<td>8</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>8</td>
</tr>
<tr>
<td>single-cell</td>
<td>7</td>
</tr>
<tr>
<td>immune</td>
<td>7</td>
</tr>
<tr>
<td>å…ç–«</td>
<td>6</td>
</tr>
<tr>
<td>Tç»†èƒ</td>
<td>5</td>
</tr>
<tr>
<td>aging</td>
<td>5</td>
</tr>
<tr>
<td>åŸºå› ç»„</td>
<td>3</td>
</tr>
<tr>
<td>è€è¯</td>
<td>3</td>
</tr>
<tr>
<td>Alzheimer</td>
<td>3</td>
</tr>
<tr>
<td>è¡°è€</td>
<td>2</td>
</tr>
<tr>
<td>å¯Œé›†</td>
<td>2</td>
</tr>
<tr>
<td>ç¥ç»</td>
<td>2</td>
</tr>
<tr>
<td>ç©ºé—´è½¬å½•ç»„</td>
<td>2</td>
</tr>
<tr>
<td>è½¬å½•ç»„</td>
<td>2</td>
</tr>
<tr>
<td>ç”Ÿä¿¡</td>
<td>2</td>
</tr>
<tr>
<td>resistance</td>
<td>2</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>2</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (19æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247547105&amp;idx=1&amp;sn=553bf03329066f30354f83305cf630c7" target="_blank" rel="noopener noreferrer">è¿™æ¬¡çœŸçš„æ˜¯Yå”çš„é”…äº†å—ï¼šä¸ºä»€ä¹ˆKEGGé€šè·¯å¯Œé›†ç»“æœä¸­çš„åˆ†ç±»æœ‰NAå‘¢ï¼Ÿ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507482&amp;idx=2&amp;sn=9ba8e9dfb2ba19b7b763f3e7a1ca6d0f" target="_blank" rel="noopener noreferrer">Nature Agingï¼šåˆ˜å…‰æ…§ç­‰å‘ç°ç¼“è§£å‰åˆ—è…ºè¡°è€æ–°ç­–ç•¥</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248655&amp;idx=4&amp;sn=d61fb5dc160b8986191d1cea60638e60" target="_blank" rel="noopener noreferrer">é¡¶åˆŠé‡Œç¨‹ç¢‘çªç ´ï¼å“ˆä½›å›¢é˜Ÿç»˜ 170 ä¸‡ T ç»†èƒå›¾è°±ï¼Œç”Ÿä¿¡æ³¨é‡Šæœ‰äº† â€œé»„é‡‘æ ‡å°ºâ€</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI4MjY5ODI1Nw==&amp;mid=2247496737&amp;idx=1&amp;sn=aabce9b1b89ff3ac78a1ff0e0f017117" target="_blank" rel="noopener noreferrer">å•ç»†èƒæµ‹åºå’Œæ·±åº¦å­¦ä¹ ç³»åˆ—ä¸‰ï¼šç»†èƒç±»å‹åˆ†ç±»å™¨</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484088&amp;idx=1&amp;sn=386a1ea4ecf9fa496c92e17580cc5c35" target="_blank" rel="noopener noreferrer">äººä½“æ·‹å·´å¾ªç¯ç³»ç»Ÿï¼ˆå»ºè®®æ”¶è—ï¼‰</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU4NjU4ODQ2MQ==&amp;mid=2247497281&amp;idx=1&amp;sn=766f7f39e0061e2c251455faac2ba4ed" target="_blank" rel="noopener noreferrer">æ–°ä¸€æœŸå•ç»†èƒå­¦ä¹ å°ç»„å³å°†å‘è½¦</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498510&amp;idx=1&amp;sn=1448143fcd1bf0dfb595acaafc79dda2" target="_blank" rel="noopener noreferrer">æ°”æ³¡å›¾-å¦‚ä½•ä¼˜é›…çš„ç»˜åˆ¶å¤šç»„å¯Œé›†ç»“æœè¿›è¡Œç±»æ¯”</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504009&amp;idx=2&amp;sn=0e12e764251e2d527cb1e8a704904174" target="_blank" rel="noopener noreferrer">è°è¯´å•åŸºå› æ²¡å‰é€”ï¼Œç»“åˆå•ç»†èƒï¼Œç©ºè½¬å’Œå®éªŒéªŒè¯ï¼Œç…§æ ·å‘8åˆ†1åŒºæ–‡ç« ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507482&amp;idx=1&amp;sn=d92587a2f073d423250ade5ea065dbb9" target="_blank" rel="noopener noreferrer">Cell Reports Medcineï¼šè°­å…°/éƒé‡‘æ³°å›¢é˜Ÿæ­ç¤ºç™«ç—«å‘ä½œç›¸å…³çš„è¡€æµ†è›‹ç™½è´¨ç»„</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2MTExNTkwNA==&amp;mid=2247573476&amp;idx=1&amp;sn=3720497fc0df676213705a37dc528792" target="_blank" rel="noopener noreferrer">Cancer Cellï¼èƒ¶è´¨ç˜¤é€ƒé€¸æ–°é¶ç‚¹</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2MTExNTkwNA==&amp;mid=2247573569&amp;idx=2&amp;sn=ffe63605d409ec07ef375284de665f24" target="_blank" rel="noopener noreferrer">è‚¿ç˜¤CRISPR Screenåœ¨çº¿å¹³å°ï¼é‡ç£…æ¨èï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523451&amp;idx=1&amp;sn=f5e3c4f13af123c1b5b945cca20f285e" target="_blank" rel="noopener noreferrer">ç‹¬å®¶å¹²è´§ | åŸºäºRè¯­è¨€çš„å•ç»†èƒå¤šç»„å­¦åˆ†ææ•™ç¨‹ï¼Œé›¶åŸºç¡€ä¹Ÿèƒ½æå®šï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248655&amp;idx=6&amp;sn=149d2874159b1f936686a41c427e3252" target="_blank" rel="noopener noreferrer">Natureï¼šscWGS+scRNAè§£å¯†å…¨åŸºå› ç»„å€å¢çš„æ¼”åŒ–åŠ¨æ€</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248655&amp;idx=3&amp;sn=9c0418262ea8205dceab2ea21ea8c160" target="_blank" rel="noopener noreferrer">åˆ«å‚»äº†ï¼å¤šç»„å­¦åªåšå…³è”å’Œé€šè·¯ï¼Ÿè¿™æ³¢è¡€äºï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248655&amp;idx=1&amp;sn=7e0a793ca685d6d6c23a6bd453536a56" target="_blank" rel="noopener noreferrer">è…¾è®¯ç™»26.6åˆ†Natureå­åˆŠï¼Œåªæœ‰ä½ æƒ³ä¸åˆ°çš„è›‹ç™½è´¨ï¼æ²¡æœ‰è¿™ä¸ªæ¨¡å‹é¢„æµ‹ä¸äº†çš„</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656510414&amp;idx=2&amp;sn=556cd0557e930022101d6f3741722234" target="_blank" rel="noopener noreferrer">æ–°å…ç–«æŠ‘åˆ¶å›è·¯ï¼å—å¼€å¤§å­¦å‘æ–‡ï¼šå¯æ”¹å–„èƒ°è…ºç™Œæ‚£è€…æ²»ç–—æ•ˆæœçš„æ–°ç­–ç•¥</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU5OTgxNzU3NQ==&amp;mid=2247558426&amp;idx=2&amp;sn=e2e8169fe2d63346f21db8c63fb46ae9" target="_blank" rel="noopener noreferrer">åŸä½è‚¿ç˜¤æ¨¡å‹æ„å»ºå›å½’ä¸“åœºå³å°†å¯åŠ¨ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503139&amp;idx=1&amp;sn=4bbf1c3509f8fe89f54a4be5b2e0ba6a" target="_blank" rel="noopener noreferrer">è¯­è¨€æ¨¡å‹ | Nat.Genet. | åŸºå› ç»„è¯­è¨€æ¨¡å‹çš„æ ¸è‹·é…¸ä¾èµ–æ€§åˆ†æå¯æ£€æµ‹åŠŸèƒ½å…ƒä»¶</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247790287&amp;idx=4&amp;sn=8cd2c41b78c9872ec314938b8cde2fb8" target="_blank" rel="noopener noreferrer">è¥¿å®‰äº¤å¤§æœ€æ–°Nature Cancerè®ºæ–‡ï¼šæ–°å‹AIç—…ç†æ¨¡å‹ï¼Œå®ç°å¤§è§„æ¨¡è‚¿ç˜¤ç­›æŸ¥åŠç»†ç²’åº¦é‡åŒ–è¯Šæ–­</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (44æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290305" target="_blank" rel="noopener noreferrer">GSE290305 é˜¿å°”èŒ¨æµ·é»˜ç—…å°é¼ æ¨¡å‹æµ·é©¬ä½“ä¸­è¡¨è§‚åŸºå› ç»„å’Œè½¬å½•ç»„æ”¹å˜å…ˆäºæ·€ç²‰æ ·å˜æ€§[RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303144" target="_blank" rel="noopener noreferrer">GSE303144 IL-9ä¿¡å·é€šè·¯å°†CAR Tç»†èƒçš„å‘½è¿å¯¼å‘CD8+è®°å¿†å’ŒCD4+å¢æ®–çŠ¶æ€ï¼Œä»è€Œå¢å¼ºæŠ—è‚¿ç˜¤ç–—æ•ˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287512" target="_blank" rel="noopener noreferrer">GSE287512 MP0317ï¼ˆä¸€ç§FAPxCD40 DARPinï¼‰é€šè¿‡è‚¿ç˜¤å±€éƒ¨CD40æ¿€åŠ¨ä½œç”¨é‡å¡‘è‚¿ç˜¤å¾®ç¯å¢ƒâ€”â€”ä¸€é¡¹IæœŸå•è¯æ²»ç–—ç ”ç©¶çš„ç»“æœ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281094" target="_blank" rel="noopener noreferrer">GSE281094 ä¸­åç»’è¯èŸ¹èœ•çš®é—´æœŸè‚Œè‚‰çš„ATAC-seqå’ŒRNA-seqåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310641" target="_blank" rel="noopener noreferrer">GSE310641 FluPRINT ç ”ç©¶ï¼šLAIV å…ç–«å’Œè½¬å½•ååº”çš„ç‰¹å¾åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308595" target="_blank" rel="noopener noreferrer">GSE308595 ç»†èƒç„¦äº¡è°ƒèŠ‚é¶å‘æ²»ç–—é»‘è‰²ç´ ç˜¤ä¸­çš„å¤šç§å…ç–«ç»†èƒç¾¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304438" target="_blank" rel="noopener noreferrer">GSE304438 å¼‚æŸ“è‰²è´¨è¡¨è§‚çªå˜å¯¼è‡´çº¿ç²’ä½“åŠŸèƒ½éšœç¢ï¼Œä»è€Œèµ‹äºˆæŠ—çœŸèŒè€è¯æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304360" target="_blank" rel="noopener noreferrer">GSE304360 è¿åŠ¨å‘é…µå•èƒèŒæ°§åŒ–åº”æ¿€è½¬å½•ç»„å­¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294147" target="_blank" rel="noopener noreferrer">GSE294147 é˜»æ–­å—æŸçº¿ç²’ä½“ä»ç™Œç»†èƒå‘RGS5+ MYL9+ CAFsçš„è½¬ç§»å¯é™ä½EGFRçªå˜å‹è‚ºç™Œå¯¹TKIsçš„æŒç»­è€å—æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269350" target="_blank" rel="noopener noreferrer">GSE269350 Erg çš„åŠ¨æ€è¡¨è¾¾æ§åˆ¶é€ è¡€ç³»ç»Ÿä»èƒå„¿åˆ°æˆä½“çš„æˆç†Ÿ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269184" target="_blank" rel="noopener noreferrer">GSE269184 Erg çš„åŠ¨æ€è¡¨è¾¾æ§åˆ¶é€ è¡€ç³»ç»Ÿä»èƒå„¿åˆ°æˆä½“çš„æˆç†Ÿ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310817" target="_blank" rel="noopener noreferrer">GSE310817 ä½¿ç”¨ Infinium å°é¼ ç”²åŸºåŒ–å¾®ç èŠ¯ç‰‡æ„å»ºå°é¼  DNA ç”²åŸºåŒ–å›¾è°± [EPIC é˜µåˆ—åˆ†æ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310713" target="_blank" rel="noopener noreferrer">GSE310713 ClpC1é¶å‘è‚½å¤©ç„¶äº§ç‰©å·®å¼‚æ€§åœ°æ‰°ä¹±ç»“æ ¸åˆ†ææ†èŒçš„è›‹ç™½è´¨ç»„ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310667" target="_blank" rel="noopener noreferrer">GSE310667 å¹¼å¹´ç¥ç»ç³»ç»Ÿçš„åŸºå› è¡¨è¾¾å›¾è°±ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310303" target="_blank" rel="noopener noreferrer">GSE310303 é‰´å®šå‡º UVB è¯±å¯¼çš„ TREM-1 é˜³æ€§è€å—æ€§æ ‘çªçŠ¶ç»†èƒï¼Œå¹¶å°† TREM-1 ä¿¡å·é€šè·¯ä½œä¸ºé¢„é˜² UVB è¯±å¯¼çš„å…ç–«æŠ‘åˆ¶å’Œçš®è‚¤ç™Œå˜çš„é¶ç‚¹ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310223" target="_blank" rel="noopener noreferrer">GSE310223 ç²¾ç»†åŒ–çš„ç»†èƒæ´»æ€§è¡¨è¾¾ç‰¹å¾ä¸ºé‡åŒ–å•ç»†èƒæ•°æ®ä¸­è‚¿ç˜¤å†…è¡¨å‹å¼‚è´¨æ€§æä¾›äº†ä¸€ä¸ªé¶å‘æ¡†æ¶ IV</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310222" target="_blank" rel="noopener noreferrer">GSE310222 ç²¾ç»†åŒ–çš„ç»†èƒæ´»æ€§è¡¨è¾¾ç‰¹å¾ä¸ºé‡åŒ–å•ç»†èƒæ•°æ®ä¸­è‚¿ç˜¤å†…è¡¨å‹å¼‚è´¨æ€§æä¾›äº†ä¸€ä¸ªé¶å‘æ¡†æ¶ III</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310220" target="_blank" rel="noopener noreferrer">GSE310220 ç²¾ç»†åŒ–çš„ç»†èƒæ´»æ€§è¡¨è¾¾ç‰¹å¾ä¸ºé‡åŒ–å•ç»†èƒæ•°æ®ä¸­è‚¿ç˜¤å†…è¡¨å‹å¼‚è´¨æ€§æä¾›äº†ä¸€ä¸ªé¶å‘æ¡†æ¶ II</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310219" target="_blank" rel="noopener noreferrer">GSE310219 ç²¾ç»†åŒ–çš„ç»†èƒæ´»æ€§è¡¨è¾¾ç‰¹å¾ä¸ºé‡åŒ–å•ç»†èƒæ•°æ®ä¸­è‚¿ç˜¤å†…è¡¨å‹å¼‚è´¨æ€§æä¾›äº†ä¸€ä¸ªé¶å‘æ¡†æ¶ I</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310041" target="_blank" rel="noopener noreferrer">GSE310041 å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œçš„æ‰¹é‡ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303376" target="_blank" rel="noopener noreferrer">GSE303376 é¶å‘ç¼–è¾‘ç»„è›‹ç™½ H3K27 ä¸‰ç”²åŸºåŒ–é˜æ˜å…¶åœ¨å…‰å‘¨æœŸè°ƒæ§å¼€èŠ±ä¸­çš„é‡è¦æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298655" target="_blank" rel="noopener noreferrer">GSE298655 Arpc5 å¯¹è‚ é“å·¨å™¬ç»†èƒåŸºå› è¡¨è¾¾çš„è´¡çŒ®</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295144" target="_blank" rel="noopener noreferrer">GSE295144 ç³–å°¿ç—…é€šè¿‡æ¿€æ´»æ ‘çªçŠ¶ç»†èƒå’ŒÎ³Î´ Tç»†èƒä¸­çš„CD137L-CD137è½´åŠ å‰§ç ´åæ€§ç‚ç—‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293402" target="_blank" rel="noopener noreferrer">GSE293402 ååŒåŸºå› å®¶æ—è¿›åŒ–å¡‘é€ äº†äºŒæ€ç”Ÿç‰©çš„åŸºå› ç»„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290132" target="_blank" rel="noopener noreferrer">GSE290132 HIVè¯±å¯¼çš„æ„ŸæŸ“ç»†èƒä¸Šçš„å”¾æ¶²é…¸èšç³–ä¿ƒè¿›å…ç–«é€ƒé€¸ï¼Œé€ƒé¿é«“ç³»ç»†èƒä»‹å¯¼çš„æ€ä¼¤ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289702" target="_blank" rel="noopener noreferrer">GSE289702 PABPN1-C5è½´é€šè¿‡NF-ÎºBæ¿€æ´»ä¿ƒè¿›è‚ç»†èƒç™Œè¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283061" target="_blank" rel="noopener noreferrer">GSE283061 æ ¸å¤–æ³Œä½“é¶å‘å¤åˆç‰©åœ¨å…¨åŸºå› ç»„èŒƒå›´å†…è°ƒæ§ä¸‰ç»´æŸ“è‰²è´¨ç›¸äº’ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279437" target="_blank" rel="noopener noreferrer">GSE279437 GLP-1Ræ¿€åŠ¨å‰‚çš„åŠŸèƒ½æ€§å’Œå¤šç»„å­¦æŠ—è¡°è€ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE211986" target="_blank" rel="noopener noreferrer">GSE211986 å°†äººç±»ç¥ç»èƒ¶è´¨ç¥–ç»†èƒç§»æ¤åˆ°æˆå¹´äº¨å»·é¡¿ç—…å°é¼ ä½“å†…å¯æŒ½æ•‘ç¥ç»å…ƒç»“æ„å’ŒæŸäº›è¡Œä¸ºç‰¹å¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE154099" target="_blank" rel="noopener noreferrer">GSE154099 PAXT/NEXT é¶å‘ RNA å¤–æ³Œä½“é€šè¿‡é»è¿è›‹ç™½ä»‹å¯¼çš„é•¿ç¨‹æ¥è§¦è°ƒèŠ‚åä¹‰è½¬å½•æœ¬ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE154083" target="_blank" rel="noopener noreferrer">GSE154083 PAXT/NEXT é¶å‘ RNA å¤–æ³Œä½“é€šè¿‡é»è¿è›‹ç™½ä»‹å¯¼çš„é•¿ç¨‹æ¥è§¦è°ƒèŠ‚åä¹‰è½¬å½•æœ¬ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310289" target="_blank" rel="noopener noreferrer">GSE310289 PLK3æŠ‘åˆ¶å‰‚æ²»ç–—å¯¹é™æ¯CD4+ Tç»†èƒæ•´ä½“è½¬å½•ç»„çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310288" target="_blank" rel="noopener noreferrer">GSE310288 PLK3æŠ‘åˆ¶å‰‚æ²»ç–—å¯¹é™æ¯CD4+ Tç»†èƒæ•´ä½“è½¬å½•ç»„çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309497" target="_blank" rel="noopener noreferrer">GSE309497 ç”¨æˆ·è‡ªå®šä¹‰è‚½åº“å®ç°ç™Œç—‡æŠ—åŸçš„çµæ•ç›´æ¥æ£€æµ‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290397" target="_blank" rel="noopener noreferrer">GSE290397 é˜¿å°”èŒ¨æµ·é»˜ç—…å°é¼ æ¨¡å‹æµ·é©¬ä½“ä¸­è¡¨è§‚åŸºå› ç»„å’Œè½¬å½•ç»„æ”¹å˜å…ˆäºæ·€ç²‰æ ·å˜æ€§ [BiSulfite-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290154" target="_blank" rel="noopener noreferrer">GSE290154 è¡¨è§‚åŸºå› ç»„å’Œè½¬å½•ç»„æ”¹å˜å…ˆäºé˜¿å°”èŒ¨æµ·é»˜ç—…å°é¼ æ¨¡å‹æµ·é©¬ä¸­çš„æ·€ç²‰æ ·å˜æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310831" target="_blank" rel="noopener noreferrer">GSE310831 åˆ©ç¾æ›¿ç½—åœ¨ä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³æ€§è„‚è‚ªæ€§è‚ç‚ï¼ˆMASHï¼‰ä¸­çš„ç»†èƒå’Œåˆ†å­æœºåˆ¶ï¼šä¸€é¡¹è½¬å½•ç»„åˆ†æç ”ç©¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310290" target="_blank" rel="noopener noreferrer">GSE310290 æ—©æœŸç”Ÿå‘½å¾®ç”Ÿç‰©ç¾¤å½±å“éª¨é«“é€ è¡€å‰ä½“ç»†èƒçš„é•¿æœŸåŸºå› è¡¨è¾¾å’Œè¡¨è§‚åŸºå› ç»„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310020" target="_blank" rel="noopener noreferrer">GSE310020 TGFÎ±æ˜¯è¡°è€è¿‡ç¨‹ä¸­æ¯›å›ŠåŠŸèƒ½æ‰€å¿…éœ€çš„ï¼Œå…¶ç¼ºå¤±ä¼šå¯¼è‡´è¿›è¡Œæ€§è„±å‘ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303648" target="_blank" rel="noopener noreferrer">GSE303648 Rb1 ç¼ºé™·ä¸ ATR å’Œ PKMYT1 å…±æŠ‘åˆ¶åœ¨ä¹³è…ºç™Œä¸­è¯±å¯¼åˆæˆè‡´æ­»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295626" target="_blank" rel="noopener noreferrer">GSE295626 å»æ³›ç´ åŒ–é…¶OTUD1é€šè¿‡ç ´åRAD23B/XPCçš„ç¨³å®šæ€§æ¥è°ƒæ§éå°ç»†èƒè‚ºç™Œå¯¹é¡ºé“‚åŒ–ç–—çš„æ•æ„Ÿæ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282471" target="_blank" rel="noopener noreferrer">GSE282471 æ—¥æœ¬é»‘è‰²ç´ ç˜¤çš„åŸºå› ç»„å’Œè½¬å½•ç»„åˆ†ææ­ç¤ºäº†å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚ååº”è€…çš„å€™é€‰ç”Ÿç‰©æ ‡å¿—ç‰©ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280706" target="_blank" rel="noopener noreferrer">GSE280706 RNA-seq æ—¶é—´åºåˆ—åˆ†æ Nudt21 KO å’Œ Nudt21 ä½è¡¨è¾¾å‹é£Ÿç®¡åŸºåº•ç»†èƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218499" target="_blank" rel="noopener noreferrer">GSE218499 æ¶¡è™«å†ç”Ÿç¥ç»å†…åˆ†æ³Œæ§åˆ¶ï¼ˆRNAi scRNA-seqï¼‰</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-21 21:34</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>